FDA issued a Warning Letter to Opto-Pharm Pte Ltd. on 3/16/2017 for a previous inspection.
483 Opto-Pharm Pte Jan 2019

483 Opto-Pharm Pte Jan 2019

Jennifer Gogley FDA, Anastasia Shields FDA$119.00 - Available Now

FDA investigators audited the Opto-Pharm Pte - Singapore, Singapore facility and issued inspectional observations (via FDA 483) on 25 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jan 2019
  • Location: Singapore, Singapore
  • FEI: 3005320466
Add To Cart